- FoI Number
- 2023-778
- Subject
- Urothelial Cancer
- Date Received
- 12/03/2024
- Request and Response
-
- Q1. How many patients were treated for Urothelial cancer (any stage) in the past 3 months with the following treatments?
- Atezolizumab (Tecentriq)
- Avelumab (Bavencio)
- Carboplatin single agent or in any other combination
- Carboplatin with Gemcitabine
- Carboplatin with Paclitaxel
- Cisplatin single agent or in any other combination
- Cisplatin with Gemcitabine
- Nivolumab (Opdivo)
- Pembrolizumab (Keytruda)
- Other active systemic anti-cancer therapy
- Palliative care only
Zero
